Artemisinin-based combination therapy in pregnant women in Zambia: efficacy, safety and risk of recurrent malaria.

Malaria Journal
Michael NamboziUmberto D'Alessandro

Abstract

In Zambia, malaria is one of the leading causes of morbidity and mortality, especially among under five children and pregnant women. For the latter, the World Health Organization recommends the use of artemisinin-based combination therapy (ACT) in the second and third trimester of pregnancy. In a context of limited information on ACT, the safety and efficacy of three combinations, namely artemether-lumefantrine (AL), mefloquine-artesunate (MQAS) and dihydroartemisinin-piperaquine (DHAPQ) were assessed in pregnant women with malaria. The trial was carried out between July 2010 and August 2013 in Nchelenge district, Luapula Province, an area of high transmission, as part of a multi-centre trial. Women in the second or third trimester of pregnancy and with malaria were recruited and randomized to one of the three study arms. Women were actively followed up for 63 days, and then at delivery and 1 year post-delivery. Nine hundred pregnant women were included, 300 per arm. PCR-adjusted treatment failure was 4.7% (12/258) (95% CI 2.7-8.0) for AL, 1.3% (3/235) (95% CI 0.4-3.7) for MQAS and 0.8% (2/236) (95% CI 0.2-3.0) for DHAPQ, with significant risk difference between AL and DHAPQ (p = 0.01) and between AL and MQAS (p = 0.03) treatme...Continue Reading

References

Sep 1, 1991·The Journal of Pediatrics·J L BallardR Lipp
Nov 1, 1995·Transactions of the Royal Society of Tropical Medicine and Hygiene·F O ter KuileN J White
Jan 1, 1996·The American Journal of Tropical Medicine and Hygiene·R W SteketeeJ G Breman
May 1, 1997·Transactions of the Royal Society of Tropical Medicine and Hygiene·C LuxemburgerN J White
Aug 12, 2008·Current Drug Safety·François NostenBernard Brabin
Feb 5, 2010·The Lancet Infectious Diseases·Stephen J RogersonSteven R Meshnick
Jun 1, 2010·The Lancet Infectious Diseases·Nicholas M DouglasRic N Price
Sep 13, 2011·The Journal of Infectious Diseases·J R PoespoprodjoR N Price
Oct 7, 2011·Clinical Pharmacokinetics·Kyle J Wilby, Mary H H Ensom
Jan 3, 2013·Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology·L J SalomonG Yeo
Feb 13, 2014·Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'obstétrique Et Gynécologie Du Canada : JOGC·Kimberly ButtUNKNOWN DIAGNOSTIC IMAGING COMMITTEE
Sep 30, 2015·The American Journal of Tropical Medicine and Hygiene·Jessie PinchoffUNKNOWN Southern Africa International Centers of Excellence for Malaria Research
Mar 11, 2016·The New England Journal of Medicine·UNKNOWN PREGACT Study GroupJoyce Mulenga
Mar 24, 2016·The American Journal of Tropical Medicine and Hygiene·Smita DasUNKNOWN Southern Africa International Centers of Excellence for Malaria Research Team

❮ Previous
Next ❯

Citations

Sep 30, 2021·The Journal of Asthma : Official Journal of the Association for the Care of Asthma·Haiyan GaoYibing Zhu

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR

Clinical Trials Mentioned

NCT00852423

Software Mentioned

MACRO
Nchelenge

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.